Results 1 to 10 of about 112,202 (290)
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients [PDF]
International Journal of Nephrology and Renovascular Disease, 2023 Intissar Haddiya,1,2 Siria Valoti3 1Department of Nephrology, Faculty of Medicine and Pharmacy, University Mohamed Premier, Oujda, Morocco; 2Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, University ...
Haddiya I, Valoti S
doaj +2 more sources
Beta-blockers and asthma. [PDF]
Heart, 1978 In a single-blind, randomised, crossover study in 10 asthmatic patients, the effects of approximately equipotent oral doses of 3 cardioselective beta-blockers-atenolol (100 mg), metoprolol (100 mg), and acebutolol (300 mg)-and 4 non-cardioselective beta-blockers-proranolol (100 mg), oxprenolol (100 mg), pindolol (5 mg), and timolol (10 mg) upon FEV1 ...
Peter Decalmer +4 more
openalex +4 more sources
By inhibiting β-adrenergic receptors, beta-blockers lower blood pressure and heart rate and are used to treat cardiovascular illnesses such as hypertension, angina, arrhythmias, and heart failure. Variations in these medications' oral absorption, distribution, hepatic metabolism, and renal excretion impact their therapeutic utility.
Farzam K, Jan A.
europepmc +2 more sources
Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats [PDF]
BiomedicinesBeta-blockers are first-line drugs in the treatment of chronic heart failure (CHF). However, there is no consensus on the specific effects of the beta-blockers of the I-III generation on energy metabolism in CHF.
Igor Belenichev +7 more
doaj +2 more sources
Frontiers in Pharmacology, 2021 Objectives: Rheumatoid arthritis (RA) is an independent nontraditional risk factor for incidence of myocardial infarction (MI) and post-MI outcome is impaired in the RA population.
Sheng-Fu Liu +14 more
doaj +1 more source
Neuropsychiatric Consequences of Lipophilic Beta-Blockers
Medicina, 2021 Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field.
Sabina Alexandra Cojocariu +5 more
doaj +1 more source
An apology for beta blockers [PDF]
Journal of Hepatology, 2014 might have stumbled across other rather informative (and much We read with interest the recent review on beta-blockers in cirrhosis by Ge and Runyon [1]. This topic is of great importance, as non-selective beta blockers are a pharmacological mainstay in the management of patients with cirrhosis; the amount of evidence has been increasing substantially ...
Ulrich Thalheimer +2 more
openaire +2 more sources
Journal of Medical Sciences, 2022 Background: Beta-blockers are widely used for the treatment of arrhythmia, hypertension, and congestive heart failure. Major trauma causes significant blood loss and subsequent tachycardia and hypotension.
Jen-Chun Wang +5 more
doaj +1 more source
Beta-blockers for hypertension [PDF]
Cochrane Database of Systematic Reviews, 2017 Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on mortality and cardiovascular disease (CVD) when used in people with heart failure or acute myocardial infarction. Beta-blockers were thought to have similar beneficial effects when used as first-line
Wiysonge, Charles S. +4 more
openaire +4 more sources